4
Changes in Ownership
Viridian Therapeutics, Inc.\DE Filed Acc 0000899243-22-013858
Chief Executive Officer sold 30,000 shares at an average $18.92 ($567,636)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Violin Jonathan Chief Executive Officer | 2022-04-01 | Sale | −26,400 | $18.92 | $499,488 | 544,505 | D |
| Violin Jonathan Chief Executive Officer | 2022-04-04 | Sale | −3,600 | $18.93 | $68,148 | 540,905 | D |
| Open-market sales · 30,000 sh · avg $18.92 · $567,636 | |||||||
Loading xslF345X03/doc4.xml…